Vir Biotechnology shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Vir Biotechnology
Tip: Access up to 7 years of quarterly data
All positions including Vir Biotechnology held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vir Biotechnology by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $926k | 92k | 10.06 |
| 2023-09-30 | $754k | 80k | 9.37 |
| 2023-06-30 | $2.1M | 89k | 23.27 |
| 2023-03-31 | $2.1M | 89k | 23.27 |
| 2022-12-31 | $1.8M | 72k | 25.31 |
| 2022-09-30 | $1.2M | 63k | 19.28 |
| 2022-06-30 | $2.0M | 79k | 25.47 |
| 2022-03-31 | $1.7M | 68k | 25.72 |
| 2021-12-31 | $2.7M | 65k | 41.87 |
| 2021-09-30 | $2.8M | 64k | 43.52 |
| 2021-06-30 | $3.0M | 63k | 47.28 |
| 2021-03-31 | $516k | 10k | 51.27 |
| 2020-12-31 | $269k | 10k | 26.78 |
| 2020-09-30 | $4.4M | 128k | 34.33 |
| 2020-06-30 | $6.1M | 150k | 40.97 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas